Plain English Summary
Background and study aims
Ovarian cancer is a common form of cancer that often returns after treatment.Having cancer return can be traumatizing, causing mental distress. Mindfulness is a technique that aims patients live life in a present moment and could help patients with recurrent ovarian cancer. The aim of this study is to explore the feasibility of delivering a 6-week mindfulness based group support intervention to a cohort of ovarian cancer patients who have experienced disease recurrence.
Who can participate?
Woman aged 18 and older who have a confirmed ovarian cancer.
What does the study involve?
All participants receive a 6-week mindfulness-based intervention comprising a total of 8.5 contact hours. The programme has been specifically adapted and modified for cancer patients based around extensive qualitative research to ensure its applicability and acceptability and in this capacity it has been successfully trialled in a population of stage 4 breast cancer patients.
What are the possible benefits and risks of participating?
Not provided at time of registration.
Where is the study run from?
Queen Alexandra Hospital (UK)
When is the study starting and how long is it expected to run for?
May 2016 to May 2017
Who is funding the study?
National Institute for Health Research (UK)
Who is the main contact?
Dr Sam Watts (Scientific)
Dr Sam Watts
Aldermoor Health Centre
+44 (0)2380 241085
A six-week programme of group mindfulness sessions to improve mental health and wellbeing in patients with recurrent ovarian cancer: a feasibility study
The aim of this study is to explore the feasibility of delivering a 6-week mindfulness based group support intervention to a cohort of ovarian cancer patients who have experienced disease recurrence.
Berkshire Research Ethics Committee, 30/08/2016, ref: 16/SC/0415
Non-randomised; Interventional; Design type: Treatment, Complementary Therapy, Psychological & Behavioural
Primary study design
Secondary study design
Non randomised study
Quality of life
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Specialty: Cancer, Primary sub-specialty: Gynaecological Cancers; UKCRC code/ Disease: Cancer/ Malignant neoplasms of female genital organs
All participants receive a 6-week mindfulness-based intervention comprising a total of 8.5 contact hours. The intervention has been specifically adapted and modified for cancer patients based around extensive qualitative research to ensure its applicability and acceptability and in this capacity it has been successfully trialled in a population of stage 4 breast cancer patients.
Primary outcome measures
1. Recruitment rate
2. Response rates
3. Number of patients completing the intervention
4. Number of patients completing the 6 month follow-up
5. Qualitative assessment of the intervention
6. Quantitative data analysis
Secondary outcome measures
3. Quality of life
4. Diurnal cortisol variations
Overall trial start date
Overall trial end date
Participant inclusion criteria
1. Any confirmed recurrence of OvCa at any stage
2. Aged 18 years and above
3. Willing to participate and provide informed consent
4. Fluent English (questionnaires validated and interviews conducted in English)
Target number of participants
Planned Sample Size: 30; UK Sample Size: 30
Participant exclusion criteria
1. Additional cancer diagnoses
2. Any significant mental illness (i.e. overt psychosis, history of suicidal ideation) but not to include clinical depression and/or anxiety
3. Receiving any other psychological therapy
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
Queen Alexandra Hospital
Southwick Hill Road Cosham
National Institute for Health Research
Funding Body Type
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting